Literature DB >> 8454256

Ossifying fibromyxoid tumour of soft parts: immunohistochemical and ultrastructural analysis.

J B Schofield1, T Krausz, G W Stamp, C D Fletcher, C Fisher, J G Azzopardi.   

Abstract

Ossifying fibromyxoid tumour of soft parts is a recently described benign neoplasm which usually presents in soft tissue. The histogenesis or pattern of differentiation is a source of controversy. Thirteen cases are reported herein. All arose in adults, principally on the upper trunk or head and neck region. None recurred. All but one tumour showed a shell of lamellar bone, laid down by reactive osteoblasts, at the tumour-host interface. The characteristic laciform, glomoid and fascicular patterns, usually in combination, necessitate differential diagnosis from chondroid, smooth muscle and neural tumours especially. Immunohistochemistry revealed positivity for S-100 protein in 10/12, desmin in 7/10 and smooth muscle actin in 4/8. Ultrastructural examination of four cases revealed prominent intermediate filaments, without myofilamentous organization, and a discontinuous external lamina. Immunoelectronmicroscopy localized desmin positivity to the filamentous meshwork. Differentiation therefore appears to take the form of an incomplete neural and smooth muscle phenotype, without evidence of complete maturation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454256     DOI: 10.1111/j.1365-2559.1993.tb00088.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  10 in total

1.  Atypical ossifying fibromyxoid tumor unusually located in the mediastinum: report of a case showing mosaic loss of INI-1 expression.

Authors:  Shogo Tajima; Kenji Koda
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Giant atypical ossifying fibromyxoid tumour of the calf.

Authors:  Srinivasan Harish; Alexander Polson; Paul Morris; Charles Malata; Meryl Griffiths; Philip W P Bearcroft
Journal:  Skeletal Radiol       Date:  2005-09-24       Impact factor: 2.199

3.  Ossifying fibromyxoid tumor of soft parts: a clinicopathologic, proteomic, and genomic study.

Authors:  Rondell P D Graham; Sarah Dry; Xinmin Li; Scott Binder; Armita Bahrami; Susana C Raimondi; Ahmet Dogan; Subhankar Chakraborty; Joshua J Souchek; Andrew L Folpe
Journal:  Am J Surg Pathol       Date:  2011-11       Impact factor: 6.394

Review 4.  RAGE and its ligands in bone metabolism.

Authors:  Zheng Zhou; Wen-Cheng Xiong
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

Review 5.  Malignant ossifying fibromyxoid tumor of the tongue: case report and review of the literature.

Authors:  Kouji Ohta; Masayuki Taki; Ikuko Ogawa; Shigehiro Ono; Kuniko Mizuta; Shinichi Fujimoto; Takashi Takata; Nobuyuki Kamata
Journal:  Head Face Med       Date:  2013-06-24       Impact factor: 2.151

6.  Ossifying fibromyxoid tumor (OFMT) - A rare cause of a painful thumb.

Authors:  K Sharma; David Hughes; R D Harper
Journal:  Int J Surg Case Rep       Date:  2014-11-20

7.  Malignant ossifying fibromyxoid tumor of the brain treated with post-operative fractionated stereotactic radiation therapy: A case report and literature review.

Authors:  Sasha Beyer; Nikhil T Sebastian; Rahul Neal Prasad; Jacqueline Chu; Kevin Liu; Kajal Madan; William Jiang; Jayeeta Ghose; Dukagjin M Blakaj; Joshua D Palmer; Mostafa Eltobgy; Jose Otero; James B Elder; Raju R Raval
Journal:  Surg Neurol Int       Date:  2021-11-30

8.  Malignant ossifying fibromyxoid tumor of the calvaria: illustrative case.

Authors:  Jan T Hachmann; R Scott Graham
Journal:  J Neurosurg Case Lessons       Date:  2021-08-23

9.  Ossifying fibromyxoid tumor of the oral cavity: rare case report and long-term follow-up.

Authors:  Maria Eduarda Pérez-de-Oliveira; Thayná Melo de Lima Morais; Márcio Ajudarte Lopes; Oslei Paes de Almeida; Willie F P van Heerden; Pablo Agustin Vargas
Journal:  Autops Case Rep       Date:  2020-12-08

Review 10.  Ossifying Fibromyxoid tumor of soft parts in head and neck: case report and literature review.

Authors:  Ignacio A Velasco; Ran Zhang; Tiejun Li; Diancan Wang
Journal:  Diagn Pathol       Date:  2018-03-27       Impact factor: 2.644

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.